Pfizer to combine off-patent drug business with Mylan

In this video

Share

Pfizer to combine off-patent drug business with Mylan

CNBC's Meg Tirrell reports on a new Pharma deal between Pfizer and Mylan.
02:36
Mon, Jul 29 20196:55 AM EDT